好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Leukocytosis & Neutrophilia during Neurological Deterioration Negatively Impact Outcome in Acute Ischemic Stroke
Cerebrovascular Disease and Interventional Neurology
(-)
038
Authors/Disclosures
Andre Kumar No disclosure on file
David J. Dickoff, MD No disclosure on file
Michael Gillette No disclosure on file
James E. Siegler III, MD (University of Chicago) Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Sheryl Martin-Schild, MD, PhD, FAAN (Dr. Brain, Inc.) No disclosure on file
Karen C. Albright, DO, DO, PhD, MS, MPH (FDA) Dr. Albright has nothing to disclose.
Amelia K. Boehme, PhD (Columbia University) Dr. Boehme has nothing to disclose.